Author:
Chu Grace C.,Chelius Dirk,Xiao Gang,Khor Hui K.,Coulibaly Sururat,Bondarenko Pavel V.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference33 articles.
1. A. C. Herman, T. C. Boone, and H. S. Lu. Characterization, formulation, and stability of Neupogen (Filgrastim), a recombinant human granulocyte-colony stimulating factor. In R. Pearlman and Y. J. Wang (eds.), Formulation, Characterization, and Stability of Protein Drugs. Case Histories, Plenum, New York, 1996, pp. 303–328.
2. X. M. Lam, J. Y. Yang, and J. L. Cleland. Antioxidants for prevention of methionine oxidation in recombinant monoclonal antibody HER2. J. Pharm. Sci. 86:1250–1255 (1997).
3. S. A. Bernhard, A. Berger, J. H. Carter, E. Katchalski, M. Sela, and Y. Shalitin. Co-operative effects of functional groups in peptides. I. Aspartyl-serine derivatives. J. Am. Chem. Soc. 84:2421–2434 (1962).
4. T. Geiger and S. Clarke. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. J. Biol. Chem. 262:785–794 (1987).
5. J. Cacia, R. Keck, L. G. Presta, and J. Frenz. Isomerization of an aspartic acid residue in the complementarity-determining regions of a recombinant antibody to human IgE: identification and effect on binding affinity. Biochemistry 35:1897–1903 (1996).
Cited by
98 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献